Caliper's Shares Gain Back Some Ground After Sharp Drop | GenomeWeb
This article has been updated to reflect Friday's rise in Caliper's stock price.
NEW YORK (GenomeWeb News) – Shares of Caliper Life Sciences rose around 16 percent on Friday, following a drop of 21 percent on Thursday.
Caliper's shares had fallen sharply a day after the firm reported a 4 percent decline in second-quarter revenues and an analyst said his revenue outlook for the year was below the firm’s guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.